Search results

From Self-sufficiency
Jump to: navigation, search
  • [[ja:エリスロマイシン]]
    19 KB (2,731 words) - 17:52, 18 September 2010
  • [[ja:ゲンタマイシン]]
    9 KB (1,199 words) - 16:43, 27 September 2010
  • [[ja:トリメトプリム]]
    8 KB (1,056 words) - 20:12, 10 September 2010
  • [[ja:バンコマイシン]]
    31 KB (4,198 words) - 16:43, 27 September 2010
  • [[ja:エタンブトール]]
    3 KB (384 words) - 16:43, 27 September 2010
  • [[ja:ピラジナミド]]
    12 KB (1,557 words) - 16:44, 27 September 2010
  • [[ja:ストレプトマイシン]]
    9 KB (1,069 words) - 15:06, 6 July 2010
  • [[ja:カナマイシン]]
    4 KB (503 words) - 16:44, 27 September 2010
  • [[ja:フルコナゾール]]
    11 KB (1,533 words) - 16:44, 27 September 2010
  • [[ja:アムホテリシンB]]
    13 KB (1,785 words) - 16:44, 27 September 2010
  • [[ja:アシクロビル]]
    14 KB (1,878 words) - 16:44, 27 September 2010
  • [[ja:テノフォビル]]
    6 KB (871 words) - 16:45, 27 September 2010
  • ..., and [[depression (mood)|depression]], are common,<ref>Cespedes MS, Aberg JA. Neuropsychiatric complications of antiretroviral therapy. ''Drug Safety''.
    10 KB (1,441 words) - 16:45, 27 September 2010
  • ...d infants after single-dose nevirapine,<ref>{{cite journal |author=Johnson JA, Li JF, Morris L |title=Emergence of drug-resistant HIV-1 after intrapartum
    15 KB (2,090 words) - 16:45, 27 September 2010
  • [[ja:リバビリン]]
    23 KB (3,222 words) - 16:45, 27 September 2010
  • [[ja:コデイン]]
    40 KB (5,581 words) - 16:45, 27 September 2010
  • [[ja:亜硝酸ナトリウム]]
    21 KB (3,046 words) - 16:45, 27 September 2010
  • [[ja:アトロピン]]
    16 KB (2,198 words) - 16:46, 27 September 2010
  • ...d, or taken orally.<ref name="reboso">{{Cite journal|author=Reboso Morales JA, González Miranda F |title=[Ketamine] |language=Spanish |journal=Revista E [[ja:ケタミン]]
    69 KB (9,697 words) - 21:01, 24 September 2010
  • ...gov/picrender.fcgi?artid=171510&blobtype=pdf |first1=TD |first2=JF |first3=JA |issn=0066-4804}}</ref><ref>{{cite journal |author=Lawrence JW, Darkin-Ratt ...=59–69 |year=1995 |pmid=8718602 |first1=JJ |first2=HM |first3=JI |first4=JA |first5=V |first6=KA |first7=JF |issn=0065-2598 }}</ref> Ciprofloxacin can
    88 KB (11,930 words) - 16:46, 27 September 2010
  • [[ja:メチレンブルー]]
    27 KB (3,650 words) - 16:46, 27 September 2010
  • ...used severe heart block, resulting in residual encephalopathy.<ref>Tilelli JA, Smith KM, Pettignano R. Life-threatening bradyarrhythmia after massive azi [[ja:アジスロマイシン]]
    15 KB (2,008 words) - 16:46, 27 September 2010
  • ...i=10.1900/RDS.2008.5.95}}</ref><ref name=MiG>{{vcite journal |author=Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators |title=Metfo ...y significant toxic effects.<ref>{{vcite journal |author=Spiller HA, Weber JA, Winter ML, Klein-Schwartz W, Hofman M, Gorman SE, Stork CM, Krenzelok EP |
    66 KB (8,976 words) - 16:47, 27 September 2010
  • ...ieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN. | title = Comparative Effectiveness of Second-Generati [[ja:フルオキセチン]]
    52 KB (7,168 words) - 16:47, 27 September 2010
  • [[ja:活性炭]]
    41 KB (5,738 words) - 16:47, 27 September 2010
  • ...um?|journal=Proc Natl Acad Sci USA|year=2002|coauthors=Warner TD, Mitchell JA.|volume=99|issue=21|pages=13371–3|pmid=12374850 |url=http://www.pnas.org/ ...|year=2006|coauthors=Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB.|volume=119|issue=1|pages=202–7|pmid=16
    78 KB (10,918 words) - 16:52, 27 September 2010
  • [[ja:オメプラゾール]]
    17 KB (2,299 words) - 09:15, 5 September 2010
  • [[ja:アムロジピン]]
    12 KB (1,641 words) - 15:32, 16 September 2010
  • [[ja:エナラプリル]]
    5 KB (725 words) - 16:48, 27 September 2010
  • [[ja:ヒドロクロロチアジド]]
    5 KB (655 words) - 16:48, 27 September 2010
  • [[ja:ニトロプルシド]]
    9 KB (1,095 words) - 16:48, 27 September 2010
  • [[ja:フロセミド]]
    12 KB (1,678 words) - 16:48, 27 September 2010
  • ...in. 2004 Jul;110(1-2):205-14.</ref> [[thalamus]],<ref>Shyu BC, Kiritsy-Roy JA, Morrow TJ, Casey KL.Neurophysiological, pharmacological and behavioral evi ...er cell]]s.<ref>McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ. (2002). Dopamine receptor expression on human T-
    48 KB (6,470 words) - 16:48, 27 September 2010
  • [[ja:アセタゾラミド]]
    12 KB (1,686 words) - 16:48, 27 September 2010
  • [[ja:酢酸]]
    41 KB (5,915 words) - 16:49, 27 September 2010
  • [[ja:アザチオプリン]]
    11 KB (1,410 words) - 16:49, 27 September 2010
  • |author=Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB [[ja:水酸化アルミニウム]]
    10 KB (1,283 words) - 16:49, 27 September 2010
  • [[ja:グルコース]]
    23 KB (3,050 words) - 16:52, 27 September 2010
  • [[ja:サルブタモール]]
    15 KB (2,005 words) - 16:49, 27 September 2010
  • [[ja:メトクロプラミド]]
    11 KB (1,453 words) - 16:49, 27 September 2010
  • [[ja:塩化カリウム]]
    14 KB (1,921 words) - 16:49, 27 September 2010
  • ...r tissue.<ref>{{Cite journal|author=Houck JC, Sharma VK, Patel YM, Gladner JA |title=Induction of collagenolytic and proteolytic activities by anti-infla [[ja:コルチゾール]]
    41 KB (5,644 words) - 16:50, 27 September 2010
  • ...have been reported.<ref name="medtox1986-vale">{{Cite journal| author=Vale JA, Meredith TJ. | title=Acute poisoning due to non-steroidal anti-inflammator [[ja:イブプロフェン]]
    29 KB (3,955 words) - 22:17, 21 September 2010
  • [[ja:アドレナリン]]
    22 KB (2,916 words) - 16:50, 27 September 2010
  • [[ja:亜酸化窒素]]
    61 KB (8,728 words) - 16:50, 27 September 2010
  • [[ja:水銀]]
    69 KB (10,077 words) - 21:35, 20 September 2010
  • [[ja:ジドブジン]]
    21 KB (3,049 words) - 16:51, 27 September 2010
  • *In [[Japan]], morphine is classified as a narcotic under the [[:ja:麻薬及び向精神薬取締法|Narcotics and Psychotropics Control Act]] [[ja:モルヒネ]]
    87 KB (12,376 words) - 16:51, 27 September 2010
  • ...9.009}}</ref><ref name="pmid15879007">{{cite journal |author=Kis B, Snipes JA, Busija DW |title=Acetaminophen and the cyclooxygenase-3 puzzle: sorting ou [[ja:アセトアミノフェン]]
    54 KB (7,376 words) - 16:52, 27 September 2010
  • [[ja:エフェドリン]]
    21 KB (2,906 words) - 16:51, 27 September 2010

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)